| 前收市價 | 10.42 |
| 開市 | 10.19 |
| 買盤 | 10.21 x 200 |
| 賣出價 | 10.41 x 100 |
| 今日波幅 | 10.04 - 10.64 |
| 52 週波幅 | 1.81 - 15.05 |
| 成交量 | |
| 平均成交量 | 257,198 |
| 市值 | 390.726M |
| Beta 值 (5 年，每月) | 1.94 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -4.83 |
| 業績公佈日 | 2024年5月09日 - 2024年5月13日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 17.00 |
ZacksSolid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug
Solid Biosciences' (SLDB) novel gene-therapy candidate, SGT-003, gets FDA's Rare Pediatric Disease Designation for the treatment of Duchenne muscular dystrophy.
Investor's Business DailyHow Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback
Solid Biosciences is shrugging off several messy years in gene therapy development. The biotech stock has gotten a triple-digit boost.
Insider Monkey14 Stocks With Heavy Insider Buying In 2024
In this article, we will take a detailed look at 14 Stocks With Heavy Insider Buying In 2024. For a quick overview of such stocks, read our article 5 Stocks With Heavy Insider Buying In 2024. Markets await latest inflation numbers and the debate regarding soft vs hard landing is expected to persist in the Wall Street for months […]
